Company | Cap $ | P/E | P/B | P/S | ROE | ROA | ROS | L/A | P/FCF | PR | Period |
---|---|---|---|---|---|---|---|---|---|---|---|
Bellerophon Therapeutics | 1 | 2021 | |||||||||
Achilles Therapeutics | 52 | 2023q3 | |||||||||
Allakos | 118 | 2023q3 | |||||||||
Corbus Pharmaceuticals Ho... | 155 | 2023q3 | |||||||||
Vivani Medical | 101 | 2021 | |||||||||
Quince Therapeutics | 36 | 2021 | |||||||||
Canoo | 1,023 | 2021 | |||||||||
Prelude Therapeutics | 258 | 2023q2 | |||||||||
BioAtla | 116 | 2023q3 | |||||||||
Lithium Americas | 1,109 | 2022 | |||||||||
Palo Alto Networks | 85,700 | 2023 | |||||||||
Galera Therapeutics | 6 | 2021 | |||||||||
Check-Cap | 195 | 2021 | |||||||||
ARCA biopharma | 26 | 2023q3 | |||||||||
Atea Pharmaceuticals | 339 | 2023q3 | |||||||||
Madrigal Pharmaceuticals | 4,539 | 2023q1 | |||||||||
Endo International | 0 | 2023q2 | |||||||||
Aluminum Π‘orp. of China | 1,882 | 2022 | |||||||||
Greenlane Holdings | 2 | 2023q2 | |||||||||
Baozun | 138 | 2023q3 |